× Didn't find what you were looking for? Ask a question
Top Posters
Since Sunday
z
4
n
4
t
4
k
3
x
3
r
3
m
3
j
3
c
3
l
3
e
3
s
2
New Topic  
Lolol Lolol
wrote...
Posts: 749
Rep: 0 0
6 years ago
A patient, who is experiencing some angina associated with atrial tachycardia, has been placed on verapamil (Calan), a calcium channel blocker.
 
  Knowing that this medication blocks the slow calcium channels, thereby depressing phase 4 and lengthening phases 1 and 2 action potential, the nurse should assess this patient for which of the following adverse reactions?
  A)
  Bradycardia
  B)
  Ventricular tachycardia
  C)
  Sudden cardiac death
  D)
  Increased cardiac output
Read 39 times
1 Reply

Related Topics

Replies
wrote...
6 years ago
Ans:
A

Feedback:

Calcium channel blockers (CCB) are used to slow the SA node pacemaker and inhibit conduction in the AV node, slowing the ventricular response in atrial tachycardias. Therefore, the nurse should be aware that it may cause bradycardia. CCB are not known to cause VT or sudden death. These medications reduce the force of myocardial contractility, thereby decreasing myocardial O2 demand. They do not increase cardiac output.
New Topic      
Explore
Post your homework questions and get free online help from our incredible volunteers
  1466 People Browsing
Related Images
  
 341
  
 402
  
 503
Your Opinion
How often do you eat-out per week?
Votes: 81

Previous poll results: What's your favorite coffee beverage?